SecSonar.com

Nuvation Bio Inc. (NUVB)

Nuvation Bio Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Nuvation Bio Inc. (NUVB) is a Biotechnology company based in US with a market capitalization of $1.6B. Free cash flow was negative at -$173.8M. This page tracks NUVB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 273 employees · IPO Aug 26, 2020

Valuation

Valuation & price

$4.32 · as of May 17, 2026 · -54.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

5.38

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$9.54$5.81$2.08Jul 25Dec 25Jul 26Jul 7, 25$2.08Jul 9, 25$2.37Jul 11, 25$2.20Jul 15, 25$2.13Jul 17, 25$2.24Jul 21, 25$2.35Jul 23, 25$2.56Jul 25, 25$2.50Jul 29, 25$2.46Jul 31, 25$2.36Aug 4, 25$2.31Aug 6, 25$2.35Aug 11, 25$2.24Aug 13, 25$2.61Aug 15, 25$2.75Aug 19, 25$2.69Aug 21, 25$2.74Aug 25, 25$2.88Aug 27, 25$2.95Aug 29, 25$2.97Sep 3, 25$3.15Sep 5, 25$3.90Sep 9, 25$3.35Sep 11, 25$3.35Sep 16, 25$3.27Sep 18, 25$3.17Sep 22, 25$3.27Sep 24, 25$3.24Sep 26, 25$3.20Sep 30, 25$3.70Oct 2, 25$3.71Oct 6, 25$3.77Oct 8, 25$3.72Oct 10, 25$3.74Oct 14, 25$3.55Oct 16, 25$3.63Oct 21, 25$4.21Oct 23, 25$4.39Oct 27, 25$5.04Oct 29, 25$5.26Oct 31, 25$5.22Nov 4, 25$4.83Nov 6, 25$5.02Nov 10, 25$4.64Nov 12, 25$4.93Nov 14, 25$4.86Nov 18, 25$4.80Nov 20, 25$7.01Nov 25, 25$7.88Nov 28, 25$8.03Dec 2, 25$7.47Dec 4, 25$8.31Dec 8, 25$8.58Dec 10, 25$7.84Dec 12, 25$8.43Dec 16, 25$8.66Dec 18, 25$8.99Dec 22, 25$9.54Dec 24, 25$9.52Dec 29, 25$9.06Jan 2, 26$8.58Jan 6, 26$8.49Jan 8, 26$8.45Jan 12, 26$6.46Jan 14, 26$6.31Jan 16, 26$5.85Jan 21, 26$6.15Jan 23, 26$5.59Jan 27, 26$5.61Jan 29, 26$5.34Feb 2, 26$5.63Feb 4, 26$5.86Feb 9, 26$5.64Feb 11, 26$5.72Feb 13, 26$5.77Feb 18, 26$5.77Feb 20, 26$5.44Feb 24, 26$5.64Feb 26, 26$5.80Mar 2, 26$5.84Mar 4, 26$4.74Mar 6, 26$4.59Mar 10, 26$4.69Mar 12, 26$4.37Mar 17, 26$4.40Mar 19, 26$4.26Mar 23, 26$4.35Mar 25, 26$4.38Mar 27, 26$4.25Mar 31, 26$4.29Apr 2, 26$4.41Apr 7, 26$4.51Apr 9, 26$4.63Apr 13, 26$4.70Apr 15, 26$4.82Apr 17, 26$5.08Apr 22, 26$5.12Apr 24, 26$4.89Apr 28, 26$4.56Apr 30, 26$4.45May 4, 26$4.41May 6, 26$5.04May 8, 26$4.79May 12, 26$4.84May 14, 26$4.72May 18, 26$4.21May 20, 26$4.51May 22, 26$4.72May 28, 26$4.75Jun 1, 26$4.96Jun 3, 26$4.72Jun 5, 26$4.82Jun 9, 26$4.93Jun 11, 26$4.76Jun 15, 26$5.14Jun 17, 26$5.33Jun 22, 26$5.76Jun 24, 26$6.46Jun 26, 26$5.65Jul 2, 26$5.61
$2.0552-week range$9.54
Loading valuation history…

Fundamentals

Key fundamentals

$1.6B

Market cap

—

Revenue growth (YoY)

86.6%

Gross margin

-$173.8M

Free cash flow (USD)

-$519.1M

Net debt

Net cash position

27.1%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$7.9MFY 2025$62.9M
$0$62.9M

Free cash flow by year

2018 → 2025

FY 2018$-616.0KFY 2019$-25.1MFY 2020$-36.7MFY 2021$-68.5MFY 2022$-96.5MFY 2023$-68.1MFY 2024$-130.6MFY 2025$-173.8M
-$616K-$173.8M

Gross margin by year

2024 → 2025

FY 202410.1%FY 202586.6%
10.1%86.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

6

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 4, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventConvertible Notes IssuedJun 30, 2026Filing
  • Insider sellInsider Sell $753K · 10b5-1 PlanMarkel Stacy · CHIEF PEOPLE OFFICER · $753.2KJun 24, 2026Filing
  • Insider sellInsider Sell $286K · 10b5-1 PlanSauvage Philippe · Chief Financial Officer · $286.4KJun 24, 2026Filing
  • Insider sellInsider Sell $379K · 10b5-1 PlanWentworth Kerry · CHIEF REGULATORY OFFICER · $379.2KJun 24, 2026Filing
  • Insider buyInsider Buy $118KMashal Robert · Director · $118.3KJun 11, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 27, 2026Filing
  • Quarterly report10-Q FiledMay 4, 2026Filing
  • 8-K eventEarnings ReleaseMay 4, 2026Filing
  • Insider sellInsider Sell $251K · 10b5-1 PlanLiu Dongfang · CHIEF MEDICAL OFFICER · $251KApr 21, 2026Filing
  • Insider sellInsider Sell $184K · 10b5-1 PlanWentworth Kerry · CHIEF REGULATORY OFFICER · $184.3KApr 21, 2026Filing

Questions

Frequently asked questions

What is Nuvation Bio Inc.'s market cap?

Nuvation Bio Inc. (NUVB) has a market capitalization of $1.6B.

What is NUVB's P/E ratio?

A meaningful P/E ratio is not available for NUVB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is NUVB's price-to-book (P/B) ratio?

NUVB trades at 5.38 times book value per share.

Are insiders buying NUVB stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 6 sells at Nuvation Bio Inc. in the last 90 days.

Same arena

Related companies in Biotechnology

OCS

Oculis Holding AG

$1.7B

ATAI

Atai Beckley N.V

$1.7B

VIR

Vir Biotechnology, Inc.

$1.6B

RXRX

Recursion Pharmaceuticals, Inc.

$1.6B

INVA

Innoviva, Inc.

$1.6B

NTLA

Intellia Therapeutics, Inc.

$1.6B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.